Trial intelligence / Profile preview

Gait Analysis After Viscosupplement Injection in Hip Osteoarthritis

NCT02086474Phase 4Completed

Sponsor
Université Laval
Start
May 2014
Primary completion
Aug 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of sodium hyaluronate in hip osteoarthritis, sponsored by Université Laval. Started May 2014; status: completed.

02

Drugs

sodium hyaluronate
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on NCT02086474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02086474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call